Skip to content

Vitamin D and Thyroid Function in patients with Anxiety and Depressive Disorder

Serum 25-Hydroxyvitamin D levels and thyroid function tests in patients with Generalized Anxiety Disorder and Depressive Disorder - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/05/066905
Enrollment
60
Registered
2024-05-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F411- Generalized anxiety disorder Health Condition 2: F33- Major depressive disorder, recurrent Health Condition 3: F32- Major depressive disorder, singleepisode

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

University college of medical sciences and Guru Teg Bahadur Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with age between 18-60 years. 2. Patient must meet criteria for: Either Primary diagnosis of Generalized Anxiety Disorder according to ICD-10 (The ICD-10 Classification of Mental and Behavioural Disorders) [Annexure 1] OR Primary diagnosis of Depressive episode- Mild, moderate or severe, or Recurrent Depressive Disorder according to ICD-10 (The ICD-10 Classification of Mental and Behavioural Disorders) [Annexure 2] 3. Patients should be able to read Hindi/English

Exclusion criteria

Exclusion criteria: 1. Lifetime ICD-10 diagnosis of schizophrenia, schizoaffective or bipolar disorders. 2. Patients previously diagnosed with and undergoing treatment for any significant or chronic medical illness which alters vitamin D or thyroid hormone levels (renal disease, thyroid dysfunction, hepatic disease) 3. Patients consuming vitamin D supplements in the last 6 months. 4. Pregnant or lactating women. 5. Patients with substance dependence of alcohol and illicit substances (except nicotine). 6. Patients not consenting for participation in the study or for giving blood sample.

Design outcomes

Primary

MeasureTime frame
Serum 25-hydroxyvitamin D levels in patients with Generalized Anxiety Disorder and Depressive DisorderTimepoint: 1 week

Secondary

MeasureTime frame
1. To evaluate thyroid function tests in patients of Generalized Anxiety Disorder and Depressive Disorder. 2. To study the correlation of serum levels of 25-hydroxyvitamin D and thyroid function tests with severity of anxiety, if any. 3. To study the correlation of serum levels of 25-hydroxyvitamin D and thyroid function tests with severity of depression, if anyTimepoint: 1 week

Countries

India

Contacts

Public ContactDr Nikhita Loomba

University College of medical sciences and Guru Teg Bahadur Hospital

hodpsychiatry@ucms.ac.in9625900578

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026